Harvia Oyj
25.3.2026 15:00:00 CET | Globenewswire | Press release
Harvia Plc: Managers' transactions - Matias Järnefelt
Harvia Plc: Managers' transactions - Matias Järnefelt
HARVIA PLC STOCK EXCHANGE RELEASE 25 MARCH 2026 AT 4.00 P.M. EET
Harvia Plc - Managers' transactions - Matias Järnefelt
____________________________________________
Person subject to the notification requirement
Name: Järnefelt, Matias
Position: Chief Executive Officer
Issuer: Harvia Plc
LEI: 7437002ULTBOWQQOXL69
Notification type: INITIAL NOTIFICATION
Reference number: 7437002ULTBOWQQOXL69_20260325111458_25
____________________________________________
Transaction date: 2026-03-24
Venue not applicable
Instrument type: SHARE
ISIN: FI4000306873
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 4154 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 4154 Volume weighted average price: 0.00 EUR
Additional information:
Ari Vesterinen, CFO
tel. +358 40 5050 440
ari.vesterinen@harvia.com
Harvia is one of the leading companies operating in the sauna market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna market of both private and professional customers.
Harvia’s revenue totaled EUR 198,9 million in 2025. Harvia Group employs over 700 professionals in Finland, United States, Germany, Romania, China and Hong Kong, Austria, Italy and Sweden. The company is headquartered in Muurame, Finland, adjacent to its largest sauna and sauna component manufacturing facility.
Read more: https://harviagroup.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chemometec A/S5.10.2026 21:52:21 CEST | Press release
Major shareholder announcement - BlackRock, Inc.
Chemometec A/S5.10.2026 21:52:21 CEST | Pressemeddelelse
Storaktionærmeddelelse - BlackRock, Inc.
Tryg A/S5.10.2026 21:21:26 CEST | Pressemeddelelse
Storaktionærmeddelelse
Tryg A/S5.10.2026 21:21:26 CEST | Press release
Major Shareholder Announcement
Genmab A/S5.10.2026 20:49:00 CEST | Press release
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom